Clinical Trial Update: CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial at the University of Pennsylvania evaluating CART-EGFR-IL13Ra2 CAR-T cells following initial radiotherapy in newly d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CART-EGFR-IL13Ra2

Snippet

Sponsor: University of Pennsylvania | Conditions: Glioblastoma | Phase 1 | Status: RECRUITING